Posts by: Magdalena Kegel

Magdalena Kegel

Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.

January 23, 2018January 23, 2018

Transcranial Magnetic Stimulation Ineffective for Depression in Parkinson’s, Study Reports

News

Repetitive transcranial magnetic stimulation (TMS) does not appear to treat depressive symptoms in patients with Parkinson’s disease, although it may improve motor symptoms, an analysis of nine clinical trials found. But the study included ... Read more

January 9, 2018January 9, 2018

Nuplazid Review Endorses Treatment, But Pinpoints Additional Study Needs

News

Even though 60 percent of Parkinson’s Disease patients develop psychotic symptoms, it was only in 2016 that a treatment for the condition was approved. Nuplazid (pimavanserin) employs an entirely ... Read more

January 5, 2018

Deep Brain Stimulation Study in Parkinson’s Dementia Challenges Earlier Safety Concerns

News

Deep brain stimulation (DBS) may be safe for Parkinson’s disease patients who have dementia, according to a small clinical trial by University College London scientists. The study, “Bilateral Deep ... Read more

January 2, 2018

Top 10 Parkinson’s Disease Stories of 2017

News

Throughout the past year, Parkinson’s News Today has brought you news on Parkinson’s disease treatment development, clinical trials, research, and events. As we look forward to bringing you more ... Read more

December 22, 2017

Tiny Implanted Wireless Device Could Be the Next Thing in Brain Stimulation

News

An implanted wireless device that is smaller than a cubic millimeter may be the future for deep brain stimulation in Parkinson’s disease. A team of engineers at the non-profit Draper ... Read more

December 19, 2017

Parkinson’s Protein Aggregates Seen in Action Destroying Neurons in Brain

News

Researchers have uncovered how aggregates of the Parkinson’s disease-associated protein alpha-synuclein damages nerve cells. The discovery offers scientists a road map to strategies for developing new treatments for the ... Read more

November 17, 2017November 17, 2017

Deep Brain Stimulation Surgery Works Better If Patients Are Asleep, Study Suggests

News

Deep brain stimulation surgery, used to treat the effects of Parkinson’s disease, is performed better when patients are asleep rather than awake, researchers from the Oregon Health & Science ... Read more

November 15, 2017

Ultrasound Can Reduce Tremors in Severe Cases of Parkinson’s, Study Suggests

News

Ultrasound therapy can reduce the tremors of Parkinson’s patients who fail to respond to medication, a small clinical trial suggests. While the results were encouraging, larger studies are needed ... Read more

September 29, 2017

Diabetes Drug Lowered Parkinson’s Disease Risk Significantly, Study Finds

News

People with diabetes who use a group of drugs called glitazones are 28 percent less likely to develop Parkinson’s disease, report researchers from the University of Bergen (UiB) in ... Read more

September 6, 2017

Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment

News

In an unexpected finding, researchers demonstrated that certain asthma drugs might protect from developing Parkinson’s disease by lowering the production of the disease-linked protein alpha-synuclein. But researchers caution against ... Read more

Pin It on Pinterest